Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies
- PMID: 15033802
- DOI: 10.1196/annals.1299.115
Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies
Abstract
Many neurodegenerative disorders referred to as "tauopathies" are characterized by the accumulation and aggregation of Tau proteins into filaments. In these pathologies, Tau proteins are hyperphosphorylated and also abnormally phosphorylated. Moreover, they differ from each other by the preferential aggregation of isoforms exhibiting either three microtubule-binding repeats (3R) or four repeats (4R) Tau. To investigate the effects of an intracellular accumulation of Tau, we stably transfected neuroblastoma cell line SY5Y with either 3R or 4R Tau. Our data showed that an increase in intracellular Tau expression has led to their hyperphosphorylation. Conversely, an abnormal Tau phosphorylation and/or aggregation were never observed. Furthermore, SY5Y cells transfected with 4R Tau showed an increased susceptibility to cell death. Finally, in apoptotic conditions, Tau proteins were degraded at their carboxy terminus by caspase, leading to an apparent decrease in Tau phosphorylation in this region. Because truncated Tau generated during apoptosis are not commonly found in Tau aggregates, apoptotic processes may not be of interest in neurofibrillary degeneration.
Similar articles
-
Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.Ann N Y Acad Sci. 2000;920:107-14. doi: 10.1111/j.1749-6632.2000.tb06911.x. Ann N Y Acad Sci. 2000. PMID: 11193138
-
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.Brain. 2015 Nov;138(Pt 11):3345-59. doi: 10.1093/brain/awv222. Epub 2015 Jul 27. Brain. 2015. PMID: 26220942 Free PMC article.
-
From tau phosphorylation to tau aggregation: what about neuronal death?Biochem Soc Trans. 2010 Aug;38(4):967-72. doi: 10.1042/BST0380967. Biochem Soc Trans. 2010. PMID: 20658986 Review.
-
Co-Expression of Three Wild-Type 3R-Tau Isoforms Induces Memory Deficit via Oxidation-Related DNA Damage and Cell Death: A Promising Model for Tauopathies.J Alzheimers Dis. 2020;73(3):1105-1123. doi: 10.3233/JAD-191132. J Alzheimers Dis. 2020. PMID: 31884489
-
Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration.J Alzheimers Dis. 2019;69(2):339-353. doi: 10.3233/JAD-180917. J Alzheimers Dis. 2019. PMID: 31006683 Review.
Cited by
-
Sleep-wake body temperature regulates tau secretion in mice and correlates with CSF and plasma tau in humans.Res Sq [Preprint]. 2024 May 14:rs.3.rs-4384494. doi: 10.21203/rs.3.rs-4384494/v1. Res Sq. 2024. Update in: J Clin Invest. 2025 Feb 04;135(7):e182931. doi: 10.1172/JCI182931. PMID: 38798432 Free PMC article. Updated. Preprint.
-
Neurotoxic calcium transfer from endoplasmic reticulum to mitochondria is regulated by cyclin-dependent kinase 5-dependent phosphorylation of tau.J Neurosci. 2005 Apr 20;25(16):4159-68. doi: 10.1523/JNEUROSCI.0060-05.2005. J Neurosci. 2005. PMID: 15843619 Free PMC article.
-
Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.J Neurosci. 2005 Dec 14;25(50):11542-52. doi: 10.1523/JNEUROSCI.3831-05.2005. J Neurosci. 2005. PMID: 16354912 Free PMC article.
-
Tau as a biomarker of neurodegenerative diseases.Biomark Med. 2008 Aug;2(4):363-84. doi: 10.2217/17520363.2.4.363. Biomark Med. 2008. PMID: 20477391 Free PMC article.
-
Temperature-induced Artifacts in Tau Phosphorylation: Implications for Reliable Alzheimer's Disease Research.Exp Neurobiol. 2023 Dec 31;32(6):423-440. doi: 10.5607/en23025. Exp Neurobiol. 2023. PMID: 38196137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical